Inactivation of CHD1 is correlated with anchorage‐independent growth (Yu et al., 2015) and enhances the invasiveness of prostate cancer (Liu et al., 2012; Rodrigues et al., 2015). Here, CHD1 is linked to prostate carcinoma.